1. Home
  2. PAHC

as of 01-28-2026 3:26pm EST

$38.78
$0.74
-1.87%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Founded: 1946 Country:
United States
United States
Employees: N/A City: TEANECK
Market Cap: 1.6B IPO Year: 2014
Target Price: $31.25 AVG Volume (30 days): 202.2K
Analyst Decision: Hold Number of Analysts: 4
Dividend Yield:
1.22%
Dividend Payout Frequency: Quarterly
EPS: 1.67 EPS Growth: 288.74
52 Week Low/High: $16.16 - $46.42 Next Earning Date: 02-05-2026
Revenue: $1,399,676,000 Revenue Growth: 33.72%
Revenue Growth (this year): 15.34% Revenue Growth (next year): 3.28%

AI-Powered PAHC Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 73.68%
73.68%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Phibro Animal Health Corporation (PAHC)

BENDHEIM JACK

President and CEO

Sell
PAHC Jan 23, 2026

Avg Cost/Share

$40.55

Shares

1,235

Total Value

$50,083.94

Owned After

15,445

SEC Form 4

BENDHEIM JACK

President and CEO

Sell
PAHC Jan 22, 2026

Avg Cost/Share

$42.29

Shares

13,158

Total Value

$552,419.73

Owned After

15,445

BENDHEIM JACK

President and CEO

Sell
PAHC Jan 21, 2026

Avg Cost/Share

$41.68

Shares

14,687

Total Value

$612,127.72

Owned After

15,445

SEC Form 4

BENDHEIM JACK

President and CEO

Sell
PAHC Jan 15, 2026

Avg Cost/Share

$40.02

Shares

2,932

Total Value

$117,348.32

Owned After

15,445

SEC Form 4

BENDHEIM JACK

President and CEO

Sell
PAHC Jan 14, 2026

Avg Cost/Share

$40.80

Shares

3,651

Total Value

$147,983.11

Owned After

15,445

BENDHEIM JACK

President and CEO

Sell
PAHC Jan 13, 2026

Avg Cost/Share

$40.32

Shares

7,551

Total Value

$304,421.59

Owned After

15,445

SEC Form 4

BENDHEIM JACK

President and CEO

Sell
PAHC Jan 9, 2026

Avg Cost/Share

$40.16

Shares

213

Total Value

$8,554.08

Owned After

15,445

SEC Form 4

BENDHEIM JACK

President and CEO

Sell
PAHC Jan 7, 2026

Avg Cost/Share

$40.09

Shares

328

Total Value

$13,148.77

Owned After

15,445

SEC Form 4

BENDHEIM JACK

President and CEO

Sell
PAHC Dec 11, 2025

Avg Cost/Share

$40.91

Shares

5,752

Total Value

$235,404.68

Owned After

15,445

BENDHEIM JACK

President and CEO

Sell
PAHC Dec 9, 2025

Avg Cost/Share

$40.19

Shares

1,288

Total Value

$51,763.30

Owned After

15,445

SEC Form 4

Share on Social Networks: